(Q83242877)
Statements
Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies (English)
Gregory J Kubicek
Rita S Axelrod
Mitchell Machtay
Peter H Ahn
Pramila R Anne
Shannon Fogh
David Cognetti
Thomas J Myers
Walter J Curran
13 January 2012